BrainStorm Cell (BCLI) director granted 150K options at $0.70 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BrainStorm Cell Therapeutics director Anthony J. Polverino received a grant of stock options to acquire 150,000 shares of common stock at an exercise price of $0.70 per share. These options were granted under the company’s 2014 Stock Incentive Plan and are a form of equity compensation.
The options vest in two equal parts: 50% vests on the grant date and the remaining 50% vests on the six-month anniversary of the grant, provided he remains employed through each vesting date. All 150,000 options are scheduled to expire on February 26, 2036, giving a long-dated incentive tied to the company’s share performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Polverino Anthony J.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 150,000 | $0.70 | $105K |
Holdings After Transaction:
Stock Option (Right to Buy) — 150,000 shares (Direct, null)
Footnotes (1)
- Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan. The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Key Figures
Options granted: 150,000 options
Exercise price: $0.70 per share
Underlying shares: 150,000 shares
+2 more
5 metrics
Options granted
150,000 options
Stock Option (Right to Buy) grant to director
Exercise price
$0.70 per share
Conversion or exercise price of options
Underlying shares
150,000 shares
Common stock underlying granted options
Expiration date
February 26, 2036
Option expiration
Post-grant derivative holdings
150,000 options
Total derivative shares following transaction
Key Terms
Stock Option (Right to Buy), 2014 Stock Incentive Plan, vest, exercise price, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
2014 Stock Incentive Plan financial
"options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan"
vest financial
"The Stock Options shall vest as to (i) 50% of the award on the date of grant"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: 0.7000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-02-26T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did BRAINSTORM CELL THERAPEUTICS (BCLI) director Anthony J. Polverino receive in this Form 4?
Anthony J. Polverino received stock options to acquire 150,000 shares of common stock at $0.70 per share. The options were granted as equity compensation under BrainStorm’s 2014 Stock Incentive Plan, aligning part of his pay with future stock performance.
What is the exercise price of the new BCLI stock options granted to Anthony J. Polverino?
The stock options have an exercise price of $0.70 per share. This means Polverino can buy up to 150,000 BrainStorm Cell Therapeutics common shares at $0.70, regardless of the market price, once the options are vested and until they expire.
How do the BCLI options granted to Anthony J. Polverino vest over time?
The options vest in two stages: 50% of the award vests on the grant date, and the remaining 50% vests on the six-month anniversary. Vesting is conditioned on Polverino remaining employed by BrainStorm Cell Therapeutics through each respective vesting date, following the plan’s terms.
When do Anthony J. Polverino’s BCLI stock options expire?
The options are scheduled to expire on February 26, 2036. After that date, any unexercised options become worthless. This long expiration period gives Polverino many years to decide whether to exercise, depending on BrainStorm’s share price and his own circumstances.
Are the BCLI stock options reported in this Form 4 part of a compensation plan?
Yes. The footnotes state the options were granted under BrainStorm Cell Therapeutics’ 2014 Stock Incentive Plan. Such plans are typical equity compensation programs used to reward directors and executives with long-term incentives linked to company performance and shareholder value.